Project Grant S10OD040254
- The National Institutes of Health Office of the Director awarded The New York Structural Biology Center, Inc. $1.97 million on June 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire Gatan BioContinuum energy filters for three Titan Krios G2 300-kilovolt cryo-transmission electron microscopes housed at the Simons Electron Microscopy Center (SEMC). The energy filters will extend the capability of the microscopes for high-resolution data collection supporting both...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Albert Einstein College of Medicine $750,000 on May 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a Schottky field emission scanning electron microscope (FE-SEM) with serial block-face imaging capability for the Analytical Imaging Facility (AIF), a multi-user core imaging facility supporting 143 principal investigator laboratories at the institution. The FE-SEM...
- The National Institutes of Health Office of the Director awarded $3,678,588 to The New York Structural Biology Center, Inc. on July 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a gyrotron system for dynamic nuclear polarization (DNP) solid-state nuclear magnetic resonance (NMR) spectroscopy. The gyrotron will be installed on an existing wide-bore 600 megahertz NMR spectrometer at NYSBC in New York, New York, replacing an obsolete instrument installed in...
- The National Institutes of Health Office of the Director awarded The University of Texas Southwestern Medical Center $530,050 on May 15, 2026, to acquire a JEOL JEM-120I transmission electron microscope for the Electron Microscopy Core Facility (EMCF) at UT Southwestern Medical School in Dallas, Texas under the Research Infrastructure Programs (CFDA 93.351). The TEM will replace a nineteen-year-old Tecnai G2 Spirit Biotwin microscope that is nearing end-of-life, with failing cameras no longer...
- The National Institutes of Health Office of the Director awarded $674,156 to the University of Maryland, Baltimore on May 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a Talos L120C G2 transmission electron microscope from Thermo Fisher Scientific for the Electron Microscopy Core Imaging Facility (EMCIF). The 120 kilovolt TEM replaces a decommissioned 20-year-old instrument that had severely impeded ongoing biomedical research across twenty-four NIH-funded...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded $466,325 to the University of Rochester on May 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a Bruker Skyscan 1276 CMOS Edition high-resolution in vivo microCT imaging system. The system will be housed in the Biomechanics and Multimodal Tissue Imaging Core of the Center for Musculoskeletal Research at the University of Rochester School of Medicine and Dentistry...
- The National Institutes of Health Office of the Director awarded The Regents of the University of California, San Francisco $959,619 on July 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a ThermFisher Scientific L120C 120-kilovolt transmission electron microscope for the UCSF CryoEM Core Facility. The facility houses multiple electron microscopes serving over one hundred researchers across more than thirty laboratories at UCSF and neighboring institutions. The new...
- The National Institutes of Health Office of the Director awarded Texas A&M University System Health Science Center one dollar on June 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to purchase a MINFLUX 3D microscope for the Joint Microscopy Laboratory at Texas A&M University in College Station, Texas. The MINFLUX 3D microscope is a state-of-the-art pointillistic imaging and particle tracking system that achieves precision at the nanometer scale on sub-millisecond...
- The National Institute of General Medical Sciences awarded The Research Foundation For The State University Of New York, operating as Stony Brook University, $1,367,189 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop a high-speed atomic force microscope-infrared (HS-AFM-IR) instrument for real-time, label-free imaging of biomacromolecule dynamics in aqueous environments. The project will integrate atomic force microscopy with infrared imaging...
- The National Institutes of Health Office of the Director awarded Cornell University $399,750 on May 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire a LifeCanvas Technologies SmartSPIM lightsheet microscope for the Cornell Biotechnology Resource Center (BRC) Imaging Facility in Ithaca, New York. The microscope will replace an obsolete LaVision Biotec (now Miltenyi) Ultramicroscope II and enable imaging of optically cleared tissues—such as whole mouse brains, lymph...
The Department of Health and Human Services National Institutes of Health Office of the Director awarded The New York Structural Biology Center, Inc., $1.999 million on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire a Sirius XT SXT-100 soft X-ray microscope for the Simons Electron Microscopy Center (SEMC). The SXT-100 will expand SEMC's correlative microscopy capabilities and enable in situ structural biology studies at near-atomic resolution. SEMC currently operates nine Krios microscopes, four Glacios microscopes with direct detectors, and three cryo-focused ion beam microscopes, providing access and training to NIH-funded researchers across North America. The Center is housed at the New York Structural Biology Center, a consortium of nine research institutions in New York State. The acquisition addresses two primary objectives: ensuring NIH-funded researchers nationwide have access to cutting-edge instrumentation and expertise for in situ structural biology, and providing training in state-of-the-art methods to the next generation of biomedical researchers. Performance occurs in New York, New York with a period of performance from September 1, 2026, through August 31, 2027. The assistance type is Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.0m | 8/24/26 |